Skip to main navigation
Skip to search
Skip to main content
University of Luebeck Home
English
Deutsch
Home
Research Units
Experts
Publications
Projects
Prizes
Spin-Offs
Activities
Media
Search by expertise, name or affiliation
Neue Therapiemöglichkeiten des metastasierten Melanoms
Translated title of the contribution
:
New therapy options of metastasized melanoma
P. Terheyden
*
*
Corresponding author for this work
Clinic of Dermatology, Allergology and Venerology
2
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'New therapy options of metastasized melanoma'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Anti-melanoma
25%
Antitumor Effect
25%
BRAF Inhibitor (BRAFi)
50%
Clinical Relapse
25%
Inhibitor Sensitivity
25%
MEK Inhibitor (MEKi)
25%
New Lesion
25%
New Therapies
100%
Non-resectable
25%
Overall Survival
25%
Therapy Options
100%
Tumor Response
25%
Vemurafenib
50%
Pharmacology, Toxicology and Pharmaceutical Science
B Raf Kinase
16%
Medicine and Dentistry
B Raf Kinase
16%